John Congleton | BiotechTV

top of page

Mineralys CEO John Congleton describes the rational of targeting aldosterone for hypertension and discusses his company's pivotal data

He describes the science behind aldosterone and Mineralys' program lorundrostat. The company had pivotal data earlier this year and plans...

Sep 8, 2025

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

Learn more

bottom of page

Mineralys CEO John Congleton describes the rational of targeting aldosterone for hypertension and discusses his company's pivotal data

Follow BiotechTV

Sponsors

Sponsor Spotlight